| Perlman Clinic | |
|
9850 Genesee Ave Ste 320 La Jolla CA 92037-1208 | |
| (858) 864-9800 | |
| Not Available |
| Full Name | Perlman Clinic |
|---|---|
| Speciality | Clinic/Center |
| Location | 9850 Genesee Ave Ste 320, La Jolla, California |
| Authorized Official Name and Position | Mitchell Perlman (CEO) |
| Authorized Official Contact | 8585541212 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Perlman Clinic 9850 Genesee Ave Ste 320 La Jolla CA 92037-1208 Ph: (858) 554-1212 | Perlman Clinic 9850 Genesee Ave Ste 320 La Jolla CA 92037-1208 Ph: (858) 864-9800 |
| NPI Number | 1134309305 |
|---|---|
| Provider Enumeration Date | 11/05/2007 |
| Last Update Date | 09/30/2019 |
| Medicare PECOS PAC ID | 8820035884 |
|---|---|
| Medicare Enrollment ID | O20050411001333 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134309305 | NPI | - | NPPES |
| Provider Name | Teresa Dudarewicz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1679634406 PECOS PAC ID: 6901799527 Enrollment ID: I20040209001233 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jamie L Switzer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972513000 PECOS PAC ID: 3870576432 Enrollment ID: I20040612000611 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Ilan Kuperman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1336178169 PECOS PAC ID: 0840279279 Enrollment ID: I20040910000779 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Monica Perlman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780796235 PECOS PAC ID: 2466499421 Enrollment ID: I20050412000664 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Charles Michael Wright |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1104861459 PECOS PAC ID: 5799723342 Enrollment ID: I20050422000999 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Anna E Stern |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1184728834 PECOS PAC ID: 8729087853 Enrollment ID: I20061218000505 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Paula S Grayson |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1003955303 PECOS PAC ID: 1850498551 Enrollment ID: I20070514000629 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jennifer M Black |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194763326 PECOS PAC ID: 6305735739 Enrollment ID: I20071005000813 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Midori Rivera |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1821243478 PECOS PAC ID: 2062576960 Enrollment ID: I20090121000301 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Elisabeth R Evans |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194858589 PECOS PAC ID: 6406911569 Enrollment ID: I20090224000621 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Mark E Kalina |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1275638801 PECOS PAC ID: 9830247311 Enrollment ID: I20090512000111 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Pam Ferolie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1184788648 PECOS PAC ID: 2163571241 Enrollment ID: I20090520000144 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Angela R Acfalle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013983857 PECOS PAC ID: 0648316133 Enrollment ID: I20091014000531 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Sharon Strong Kim |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1144210725 PECOS PAC ID: 4183765837 Enrollment ID: I20100104000411 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Stuart L Bursten |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164494696 PECOS PAC ID: 6204969132 Enrollment ID: I20100729000394 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Robert Yuhas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700897642 PECOS PAC ID: 5698765352 Enrollment ID: I20101020000057 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Morris Wisniewski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639112246 PECOS PAC ID: 8325233257 Enrollment ID: I20101117000477 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Daisy Cube Damasco-gutierrez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700841582 PECOS PAC ID: 4082881941 Enrollment ID: I20120117000344 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | William A Pitt |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1861544850 PECOS PAC ID: 6608043005 Enrollment ID: I20120223000779 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Bahar Rahnamayi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1255561122 PECOS PAC ID: 8426211970 Enrollment ID: I20120518000530 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kate A Haggerty |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1083928337 PECOS PAC ID: 6901062264 Enrollment ID: I20120801000096 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Emily R Moreno |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396098562 PECOS PAC ID: 3971755778 Enrollment ID: I20121130000040 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Judith Cabrera |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1710202734 PECOS PAC ID: 8224282272 Enrollment ID: I20130129000341 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alan L Schneider |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639110869 PECOS PAC ID: 1153563853 Enrollment ID: I20130808000701 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Shaunak V Rana |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205046182 PECOS PAC ID: 5294992525 Enrollment ID: I20131028001862 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Catherine V Carroll |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952627937 PECOS PAC ID: 3577799204 Enrollment ID: I20131202000532 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Resham Batra |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1265401327 PECOS PAC ID: 6709801459 Enrollment ID: I20141108000196 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Thomas Dabrowski |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1295148658 PECOS PAC ID: 0941521264 Enrollment ID: I20150624000500 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Marina Udowenko |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831328616 PECOS PAC ID: 1254559123 Enrollment ID: I20150806011482 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Uri Guefen |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1275646333 PECOS PAC ID: 2668373747 Enrollment ID: I20160629000934 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jaya Maewal |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1134564982 PECOS PAC ID: 8426345729 Enrollment ID: I20160930000771 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Madalasa Bista |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1174966444 PECOS PAC ID: 7214164516 Enrollment ID: I20161209000825 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jessica B Kelley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922551324 PECOS PAC ID: 2769763200 Enrollment ID: I20161221001495 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Manuel A Moreno |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275991929 PECOS PAC ID: 3375824774 Enrollment ID: I20161222001420 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alice Lin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184769341 PECOS PAC ID: 2668618208 Enrollment ID: I20170126002572 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Erin P Vierra |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235677881 PECOS PAC ID: 1759658719 Enrollment ID: I20170522002573 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jessica Namur Chrisman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700201258 PECOS PAC ID: 5092083600 Enrollment ID: I20170622000627 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Diane Solic |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548708605 PECOS PAC ID: 7719256932 Enrollment ID: I20170703000849 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Nicholas Kahl |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821306598 PECOS PAC ID: 5890980544 Enrollment ID: I20171010002174 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Aimee M Cason |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053582734 PECOS PAC ID: 3577839448 Enrollment ID: I20171019002938 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Eugenie Lei Setiawan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871032870 PECOS PAC ID: 6709144538 Enrollment ID: I20171227000962 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Elizabeth A Symanski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538471222 PECOS PAC ID: 4183982812 Enrollment ID: I20171229000185 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alex Joseph Crotteau |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063925386 PECOS PAC ID: 6608137385 Enrollment ID: I20180220001247 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Meagan Petrek |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376925974 PECOS PAC ID: 8022323195 Enrollment ID: I20180309002328 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Yuliya Yartseva |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750881843 PECOS PAC ID: 8628330321 Enrollment ID: I20180316000648 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Mirza Raheem |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609886647 PECOS PAC ID: 3173559135 Enrollment ID: I20180516001156 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Vania Zuniga |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508371998 PECOS PAC ID: 3971868274 Enrollment ID: I20180606002832 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Courtney Lynne Miller |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1669735262 PECOS PAC ID: 0042565947 Enrollment ID: I20180618002163 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jennifer L Eastman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962854034 PECOS PAC ID: 2961757315 Enrollment ID: I20180626002419 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Susan J Taylor |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1205872827 PECOS PAC ID: 7315072840 Enrollment ID: I20181011002119 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Erinn Alexandra Case |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477802833 PECOS PAC ID: 5799936258 Enrollment ID: I20181024002605 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Sheri Ann Borbon Cameron |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1568859411 PECOS PAC ID: 9537403811 Enrollment ID: I20181128001752 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Ali Al-saleh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194110163 PECOS PAC ID: 2567709611 Enrollment ID: I20190128001114 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Nichola Clemens Linamen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265916944 PECOS PAC ID: 7315285251 Enrollment ID: I20190219000914 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Sadaf Farasat |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1255696407 PECOS PAC ID: 5092095190 Enrollment ID: I20190304000696 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Nicholas Peter Canelo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1104209048 PECOS PAC ID: 0446535108 Enrollment ID: I20190313001674 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Brenda Rodriguez |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578827663 PECOS PAC ID: 3173864741 Enrollment ID: I20190408002710 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Nicole Noel Silvestri |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013482363 PECOS PAC ID: 0840532578 Enrollment ID: I20190430001066 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Puneet Bhalrhu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1174962898 PECOS PAC ID: 5799078507 Enrollment ID: I20190520000793 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Rhodaline Tootell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1063547867 PECOS PAC ID: 2860564424 Enrollment ID: I20190521001203 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Carrie Michelle Garrigus |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1497115596 PECOS PAC ID: 0345533667 Enrollment ID: I20190711002544 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jenaya M Calderilla |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1407200306 PECOS PAC ID: 0042548075 Enrollment ID: I20190828002837 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Priya Jagasia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1679641971 PECOS PAC ID: 4385749654 Enrollment ID: I20191015003333 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Melissa Alice Mang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174168553 PECOS PAC ID: 4284068693 Enrollment ID: I20200128000450 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Lorilea Paige Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336790963 PECOS PAC ID: 7517395155 Enrollment ID: I20200314000236 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Arzoo Sadiqi |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114417581 PECOS PAC ID: 6608204243 Enrollment ID: I20200314000304 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Audrey Joan Realeza Cano |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154987634 PECOS PAC ID: 2365871050 Enrollment ID: I20200331003633 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Stacy Nicole Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679123418 PECOS PAC ID: 4789014796 Enrollment ID: I20200415000672 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Nicole Michael |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831759315 PECOS PAC ID: 7719308568 Enrollment ID: I20200602002500 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | David Leib Halpern |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326553710 PECOS PAC ID: 7618398009 Enrollment ID: I20200611001199 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jeffrey D Orr |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1336401702 PECOS PAC ID: 4284867573 Enrollment ID: I20200615003331 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jordan Gutierrez |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1699121749 PECOS PAC ID: 4587087168 Enrollment ID: I20200721002538 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Tyler David Brobst |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1598290645 PECOS PAC ID: 9739506205 Enrollment ID: I20200828000923 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Sandra Rego Alexander |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1609815091 PECOS PAC ID: 6800958281 Enrollment ID: I20200915003470 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Maisa Morris |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1497794655 PECOS PAC ID: 8022912252 Enrollment ID: I20201014001858 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Joanne Beecher-van Horn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457665424 PECOS PAC ID: 4688853740 Enrollment ID: I20201110002184 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Andrea G Bell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720685795 PECOS PAC ID: 7719399773 Enrollment ID: I20201215003021 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Anne Marie Weidner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538644380 PECOS PAC ID: 2466865506 Enrollment ID: I20210108000947 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Tracy Canonizado |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447858139 PECOS PAC ID: 7517370372 Enrollment ID: I20210115001523 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Lindsay Larson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558868281 PECOS PAC ID: 8527473776 Enrollment ID: I20210219002056 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Valerie Rose Drivick |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1609413863 PECOS PAC ID: 8325454226 Enrollment ID: I20210301001097 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Julie Joanne Heuring |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396333878 PECOS PAC ID: 8729497888 Enrollment ID: I20210503001341 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Samantha Jo Mcpherson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457918583 PECOS PAC ID: 9830500768 Enrollment ID: I20210527001627 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Monica Czypull |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831784842 PECOS PAC ID: 5395146344 Enrollment ID: I20210628002432 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Ilana Robbins Renfroe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801485545 PECOS PAC ID: 0749683084 Enrollment ID: I20210726000542 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Laila Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609323070 PECOS PAC ID: 9830487750 Enrollment ID: I20210803002340 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Loraine Iune Ysibido Grant |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346843281 PECOS PAC ID: 7315341971 Enrollment ID: I20210804003505 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Al Alam |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1174700678 PECOS PAC ID: 9133290760 Enrollment ID: I20210816002289 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Stuart J Andersen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205270956 PECOS PAC ID: 3476794777 Enrollment ID: I20210820001792 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Abigail Sanders |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023659463 PECOS PAC ID: 7113351289 Enrollment ID: I20210921003664 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Monica Monica Tilley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659912384 PECOS PAC ID: 2567896186 Enrollment ID: I20211005001103 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Bridget L Ross |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891274346 PECOS PAC ID: 6709139884 Enrollment ID: I20211029001892 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Armando Wu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700042561 PECOS PAC ID: 8123431475 Enrollment ID: I20211101002801 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kimberly Frances Brinckerhoff-hakim |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730774944 PECOS PAC ID: 5193124394 Enrollment ID: I20211102002198 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Madison Alexandra Pachoe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790354330 PECOS PAC ID: 1850789231 Enrollment ID: I20211104001379 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Brittany Polizzi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821692336 PECOS PAC ID: 2466866116 Enrollment ID: I20211117001676 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Cody Ronald Jackson |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1770715146 PECOS PAC ID: 0345506978 Enrollment ID: I20211216002632 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Suzanne Calcutt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467077610 PECOS PAC ID: 2466843503 Enrollment ID: I20211227001084 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kelly Shakya |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083386486 PECOS PAC ID: 1850782939 Enrollment ID: I20211228001157 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alina Vick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083116321 PECOS PAC ID: 6305238288 Enrollment ID: I20220126003290 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Ketevan Jorjadze |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336737840 PECOS PAC ID: 5193118537 Enrollment ID: I20220208002382 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | David Warren Hirshfield |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538127402 PECOS PAC ID: 8527183276 Enrollment ID: I20220216000392 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Emily L. Ramirez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447918628 PECOS PAC ID: 4587058086 Enrollment ID: I20220227000040 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Carina Lizeth Correa |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336519321 PECOS PAC ID: 5496141129 Enrollment ID: I20220406001629 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Raymond K Herr |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1750425542 PECOS PAC ID: 4486782505 Enrollment ID: I20220411001707 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Marisa J Merritt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720698970 PECOS PAC ID: 4183002751 Enrollment ID: I20220610000109 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Monika M Drzymalski |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1790262210 PECOS PAC ID: 0840533782 Enrollment ID: I20220628003671 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kathryn Elizabeth Roberts |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528586062 PECOS PAC ID: 6103206081 Enrollment ID: I20220708003603 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Phoebe Claire Tabaranza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295474468 PECOS PAC ID: 4880076694 Enrollment ID: I20220726002655 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Yadani Julia Al-saleh |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1083077283 PECOS PAC ID: 1759715121 Enrollment ID: I20220804003483 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alejandra Vazquez-bojorquez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1447817671 PECOS PAC ID: 3476936915 Enrollment ID: I20220817000954 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Michael Fangerow |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952697740 PECOS PAC ID: 7113147232 Enrollment ID: I20220907002819 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Chloe Braamse |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790413367 PECOS PAC ID: 6204212517 Enrollment ID: I20221010001769 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Stephanie Reittinger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013160308 PECOS PAC ID: 5294898813 Enrollment ID: I20221017002859 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Sanaya Hormozdyaran |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1750887634 PECOS PAC ID: 8729316179 Enrollment ID: I20221019002521 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Lauren Abram |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1467187310 PECOS PAC ID: 9335517606 Enrollment ID: I20221116003082 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Tyler Bates |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508575374 PECOS PAC ID: 1850760331 Enrollment ID: I20221205001808 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Linda Marie Giordano |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528777042 PECOS PAC ID: 7214306679 Enrollment ID: I20221207002514 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Marcelle Turner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1497291009 PECOS PAC ID: 5496124687 Enrollment ID: I20221209002313 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Rachel Dillon |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1871207936 PECOS PAC ID: 5092186353 Enrollment ID: I20230124001494 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jennifer Dziura |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134278005 PECOS PAC ID: 5799156840 Enrollment ID: I20230127000799 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Natalia Guiles |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164148722 PECOS PAC ID: 7416329248 Enrollment ID: I20230203002609 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Heba Ahmed |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1568969327 PECOS PAC ID: 4183979685 Enrollment ID: I20230222002034 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jennifer Baybayan Abreu |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1417656547 PECOS PAC ID: 3779957774 Enrollment ID: I20230314002056 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Julia Wiscombe Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1972656031 PECOS PAC ID: 3577928258 Enrollment ID: I20230502002368 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Michelle Deveza Gully |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801557947 PECOS PAC ID: 9638535966 Enrollment ID: I20230511002427 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Sally Anne Gomes |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1396206082 PECOS PAC ID: 3577929173 Enrollment ID: I20230524003088 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Samantha Breckon |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1518651959 PECOS PAC ID: 8628436961 Enrollment ID: I20230620001284 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Christa Steffensmeier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1639696065 PECOS PAC ID: 4880029008 Enrollment ID: I20230622002997 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Marlyn Cristina Molina |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1578996732 PECOS PAC ID: 0941660500 Enrollment ID: I20230714002182 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Tarina Porchia |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1710453709 PECOS PAC ID: 0244616167 Enrollment ID: I20230801002580 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Eladio Martinez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1033734520 PECOS PAC ID: 3476914458 Enrollment ID: I20230808000156 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Margaret Natalie-haslett Bischer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679253041 PECOS PAC ID: 4082076435 Enrollment ID: I20230816002748 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jessica Lynn Raimo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245991488 PECOS PAC ID: 5294198131 Enrollment ID: I20230825000878 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Rebecca Henry |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1750948717 PECOS PAC ID: 9234592916 Enrollment ID: I20230829000341 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Caitlin Brooks Piteck |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528749124 PECOS PAC ID: 6002279296 Enrollment ID: I20230906001953 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Almira Agosto |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1255689253 PECOS PAC ID: 7416311022 Enrollment ID: I20230915000684 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Lauren Povoli |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689388241 PECOS PAC ID: 9931563483 Enrollment ID: I20230915003171 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Natalie Ann Spang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508527847 PECOS PAC ID: 1456705482 Enrollment ID: I20230926000561 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kara Leinhos |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932600814 PECOS PAC ID: 2961857966 Enrollment ID: I20231011002448 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Aneel Henry |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1639661564 PECOS PAC ID: 7911395009 Enrollment ID: I20231012002901 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Evelyn Salaices Serna-balderas |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1215557657 PECOS PAC ID: 3870949258 Enrollment ID: I20231020000942 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Stephanie Hounnou |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1710451638 PECOS PAC ID: 1254789027 Enrollment ID: I20231205001181 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Brenda Lee Quiroz |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1003091836 PECOS PAC ID: 2264881291 Enrollment ID: I20231215000337 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Amy Susan Caporello |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154198620 PECOS PAC ID: 3678923463 Enrollment ID: I20231219004059 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Stephanie Lu |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1134994460 PECOS PAC ID: 2668822909 Enrollment ID: I20231228001413 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Tiffany Goodsite |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1063754067 PECOS PAC ID: 8820448897 Enrollment ID: I20240103002386 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Angelica Garcia Stuart |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1356963326 PECOS PAC ID: 6507217288 Enrollment ID: I20240106000497 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Dionysia Anthi Caviris |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215716881 PECOS PAC ID: 2365893724 Enrollment ID: I20240110001282 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Natily Sirri |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1134685936 PECOS PAC ID: 0547612673 Enrollment ID: I20240114000215 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Elizabeth Anne Gerbert |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1730415274 PECOS PAC ID: 3274985353 Enrollment ID: I20240115001618 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Riyan Buller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033814017 PECOS PAC ID: 1355793340 Enrollment ID: I20240115001915 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jo Jo Yan Ki Lee |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1194144725 PECOS PAC ID: 1658723655 Enrollment ID: I20240116000532 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Haley Marie Adams |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1689200081 PECOS PAC ID: 3678925690 Enrollment ID: I20240116001118 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Ashley Svendsen |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1750995866 PECOS PAC ID: 2860844552 Enrollment ID: I20240118001282 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Varinka Monica Muldawer |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1386767366 PECOS PAC ID: 5890147300 Enrollment ID: I20240121000116 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Merna Eissa |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1073163416 PECOS PAC ID: 8224480447 Enrollment ID: I20240123003246 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Abigail Portnoy |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1881357556 PECOS PAC ID: 2264884493 Enrollment ID: I20240123003502 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kimberly Anne Ayres |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1194387084 PECOS PAC ID: 5597118901 Enrollment ID: I20240201000087 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alexis Tellis Nseya |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235880295 PECOS PAC ID: 4688018773 Enrollment ID: I20240216001322 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Kim Vu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083152839 PECOS PAC ID: 4587008057 Enrollment ID: I20240223000693 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jocelyn Mcgriff |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1730516618 PECOS PAC ID: 7810332228 Enrollment ID: I20240226000954 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Jennifer Lynne Toomey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487347597 PECOS PAC ID: 3476998345 Enrollment ID: I20240301000447 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Julia Pederson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366219867 PECOS PAC ID: 1557707965 Enrollment ID: I20240307003001 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Ashley Louise Albinder |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083484356 PECOS PAC ID: 1557707742 Enrollment ID: I20240311001145 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Alicia Louise De Santi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295359412 PECOS PAC ID: 0749626950 Enrollment ID: I20240311001969 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
| Provider Name | Luna Nouri Toma |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770363632 PECOS PAC ID: 7416393574 Enrollment ID: I20240311004160 |
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
News Archive
CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
A combination of brain scans and reading tests has revealed that several regions in the brain are responsible for allowing humans to read.
NextSource BioTechnology, LLC, (NSB), an emerging Specialty Pharmaceutical Manufacturing and Marketing Company focused on Consolidating, Re-Branding and Launching "Matured & Orphan Drugs," has announced its most recent product Lomustine (CCNU), formerly known as CeeNu® by Bristol-Myers Squibb (BMS), which has officially been removed from the U.S. Food & Drug Administration (FDA) Drug Shortage List.
Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE.
› Verified 9 days ago
Prima Primary Medical Association, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9850 Genesee Ave, Suite 355, La Jolla, CA 92037 Phone: 858-202-0011 Fax: 858-202-0055 | |
Scripps Clinic Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, 201 N, La Jolla, CA 92037 Phone: 858-554-6158 | |
La Jolla Personal Physicians Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9834 Genesee Ave Ste 400, La Jolla, CA 92037 Phone: 858-587-4773 Fax: 858-587-4785 | |
Essential Healthcare Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Avenue, Suite 820, La Jolla, CA 92037 Phone: 858-453-5200 Fax: 858-453-5160 | |
Rhona H. Fink, Md & Julie A. Papatheofanis, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Ave, Suite 370, La Jolla, CA 92037 Phone: 858-362-0616 | |
Robert I Fox, Md, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Ave, #910, La Jolla, CA 92037 Phone: 858-457-2023 Fax: 858-457-2721 | |
Uc San Diego Student Health Service Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9500 Gilman Drive, La Jolla, CA 92093 Phone: 858-534-2135 Fax: 858-534-0814 |